zileuton

arachidonate 5-lipoxygenase ; Homo sapiens







111 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28846301 Zileuton 2022 Jan 2
2 34801853 Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms. 2022 Jan 1
3 35251467 5-Lipoxygenase Inhibition Protects Retinal Pigment Epithelium from Sodium Iodate-Induced Ferroptosis and Prevents Retinal Degeneration. 2022 1
4 34116165 Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells. 2021 Oct 1
5 31785932 Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery. 2020 Feb 5 2
6 31841698 Zileuton use and phenotypic features in asthma. 2020 Feb 1
7 32795513 High ability of zileuton ((±)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea) to stimulate IK(Ca) but suppress IK(DR) and IK(M) independently of 5-lipoxygenase inhibition. 2020 Nov 15 2
8 32799052 A cheminformatic study on chemical space characterization and diversity analysis of 5-LOX inhibitors. 2020 Nov 2
9 31331653 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach. 2019 Sep 1 1
10 29414995 The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study. 2018 1
11 29421656 Inhibition of 5-lipoxygenase represses neutrophils activation and activates apoptosis in pancreatic tissues during acute necrotizing pancreatitis. 2018 Mar 25 3
12 29953727 Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship. 2018 Nov 2
13 30199704 Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase. 2018 Oct 5 1
14 30321850 QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase. 2018 Dec 1
15 30410359 Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. 2018 1
16 28680195 New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis. 2017 1
17 29290980 Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin. 2017 Dec 5 2
18 27599517 5-Lipoxygenase inhibitor zileuton inhibits Ca(2+)-responses induced by glutoxim and molixan in macrophages. 2016 Jul 3
19 24662827 Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. 2015 Mar 5 1
20 25483364 Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. 2015 Feb 3
21 25597508 Management of severe acne. 2015 Jul 1
22 26412995 Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease. 2015 Fall 1
23 24525097 High concentrations of genistein exhibit pro-oxidant effects in primary muscle cells through mechanisms involving 5-lipoxygenase-mediated production of reactive oxygen species. 2014 May 2
24 23505486 Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton. 2013 3
25 24026253 Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors. 2013 Sep 11 1
26 24029553 Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometry. 2013 Oct 15 2
27 22680930 Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors. 2012 1
28 23245693 The diversity of Stemona stilbenoids as a result of storage and fungal infection. 2012 Dec 28 1
29 21299475 Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. 2011 Feb 1
30 21833474 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma. 2011 Nov-Dec 2
31 20880396 The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. 2010 Oct 4
32 19214143 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. 2009 Mar 2
33 19280518 2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: implications for toxicity associated with zileuton. 2009 Mar 1
34 20436887 Zileuton, a new efficient and safe systemic anti-acne drug. 2009 May 1
35 18927292 Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. 2008 Oct 15 1
36 21437139 Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. 2008 Dec 9 1
37 17258303 Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton. 2007 May 1
38 17394438 Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease. 2007 Apr 2
39 17722971 Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma. 2007 1
40 17982097 FcepsilonRI- and Fcgamma receptor-mediated production of reactive oxygen species by mast cells is lipoxygenase- and cyclooxygenase-dependent and NADPH oxidase-independent. 2007 Nov 15 1
41 16681569 Is there a role for antileukotrienes in urticaria? 2006 May 1
42 15604543 Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. 2005 2
43 15705997 The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude. 2005 Feb 1
44 15475461 Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. 2004 Oct 1 1
45 15501964 Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. 2004 Oct 15 1
46 12735786 Benefit-risk assessment of antileukotrienes in the management of asthma. 2003 1
47 12756111 A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. 2003 May 1
48 12923360 The role of leukotriene inhibitors in patients with paranasal sinus disease. 2003 Jun 1
49 12949886 Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma. 2003 Sep 1
50 14570767 Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. 2003 Nov 2